πŸ‡ΊπŸ‡Έ FDA
Patent

US 9228171

Regulatory B cells (tBREGS) and their use

granted A61KA61K2035/122A61K2035/124

Quick answer

US patent 9228171 (Regulatory B cells (tBREGS) and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2035/122, A61K2035/124, A61K2239/31, A61K2239/38